Cord-Blood Transplants from Unrelated Donors in Patients with Hurler's Syndrome

New England Journal of Medicine

Volumn 350, Issue 19, 2004, Pages 1960-1969

  Staba, Susan L ^a   Escolar, Maria L ^b   Poe, Michele ^b   Kim, Young ^c   Martin, Paul L ^a   Szabolcs, Paul ^a   Allison Thacker, June ^a   Wood, Susan ^a   Wenger, David A ^d   Rubinstein, Pablo ^e   Hopwood, John J ^f   Krivit, William ^g   Kurtzberg, Joanne ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c EMMES CORPORATION   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e NEW YORK BLOOD CENTER   (United States)

^f WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^g UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; LEVO IDURONIDASE; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BODY WEIGHT; BONE MARROW TRANSPLANTATION; CELL COUNT; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE COURSE; DISEASE SEVERITY; DONOR; ENZYME ACTIVITY; FEMALE; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HUMAN; HURLER SYNDROME; INFANT; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPTOMATOLOGY; WHOLE BODY RADIATION; BLOOD DONOR; CHILD DEVELOPMENT; DISEASE FREE SURVIVAL; FETUS BLOOD; FOLLOW UP; GROWTH; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; NEUTROPHIL; NEWBORN; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; TRANSPLANTATION;

BLOOD DONORS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COGNITION; DISEASE-FREE SURVIVAL; FEMALE; FETAL BLOOD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; GROWTH; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDURONIDASE; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; MALE; METHYLPREDNISOLONE; MUCOPOLYSACCHARIDOSIS I; NEUTROPHILS; TRANSPLANTATION CONDITIONING;

EID: 2342535103     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032613     Document Type: Article

References (33)

1. Neufeld BF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic & molecular bases of inherited disease. 8th ed. Vol. 3. New York: McGraw-Hill, 2001: 3421-52.
2. Resnick JM, Krivit W, Snover DC, et al. Pathology of the liver in mucopolysaccharidosis: light and electron microscopic assessment before and after bone marrow transplantation. Bone Marrow Transplant 1992; 10:273-80.
3. Hobbs JR, Hugh-Jones K, Barrett AJ, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981;2:709-12.
4. Braunlin EA, Rose AG, Hopwood JJ, Candel RD, Krivit W. Coronary artery patency following long-term successful engraftment 14 years after bone marrow transplantation in the Hurler syndrome. Am J Cardiol 2001;88:1075-7.
5. Vinallonga X, Sanz N, Balaguer A, Miro L, Ortega JJ, Casaldaliga J. Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone transplantation. Pediatr Cardiol 1992;13:107-9.
6. Summers CG, Purple RL, Krivit W, et al. Ocular changes in the mucopolysaccharidoses after bone marrow transplantation: a preliminary report. Ophthalmology 1989; 96:977-85.
7. Shapiro EG, Lockman LA, Balthazor M, Krivit W. Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995;18:413-29.
8. Krivit W, Peters C, Shapiro EG. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Marteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 1999;12:167-76.
9. Krivit W, Henslee-Downey J, Klemperer M, et al. Survival in Hurler's disease following bone marrow transplantation in 84 patients. Bone Marrow Transplant 1995;15: Suppl 1:S182-S185.
10. Whitley CB, Belani KG, Chang PN, et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 1993;46:209-18.
11. Peters C, Balthazor M, Shapiro BG, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996;87:4894-902.
12. Peters C, Shapiro EG, Krivit W. Hurler syndrome: past, present, and future. J Pediatr 1998;133:7-9.
13. Guffon N, Souillet G, Maire I, Straczek J, Guibaud P. Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1999;133:119-25.
14. Peters C, Shapiro EG, Anderson J, et al. Hurler syndrome. II. Outcome of HLA-genotypically identical sibling and HLA-haplo-identical related donor bone marrow transplantation in fifty-four children. Blood 1998; 91:2601-8.
15. Cowan M. Bone marrow transplantation for the treatment of genetic diseases. Clin Biochem 1991;24:375-81.
16. Whitley CB, Ramsay NK, Kersey JH, Krivit W. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction. Birth Defects Orig Artic Ser 1986; 22:7-24.
17. Fleming DR, Henslee-Downey PJ, Ciocci G, et al. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-L. Pediatr Transplant 1998;2:299-304.
18. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335:157-66.
19. Gluckman E, Broxmeyer HE, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989;321:1174-8.
20. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-90.
21. Wenger DA, Williams C. Screening for lysosomal disorders. In: Hommes FA, ed. Techniques in diagnostic human biochemical genetics: a laboratory manual. New York: Wiley-Liss, 1991:587-617.
22. deGasperi R, Raghavan SS, Gama Sosa MA, et al. Measurement from normal umbilical cord blood of four lysosomal enzyme activities: α-L-iduronidase (Hurler), galactocerebrosidase (globoid cell leukodystrophy), arylsulfatase A (metachromatic leukodystrophy), arylsulfatase B (MaroteauxLamy). Bone Marrow Transplant 2000;25: 541-4.
23. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci U S A 1995;92:10119-22.
24. Jacobson P, Prak JJ, DeFor TE, et al. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:855-61.
25. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-8.
26. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695-706.
27. Ashton JJ, Brooks DA, McCourt PA, Muller VJ, Clements PR, Hopwood JJ. Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from mucopolysaccharidosis type I patients. Am J Hum Genet 1992;50:787-94.
28. Masterson EL, Murphy PG, O'Meara A, Moore DP, Dowling FE, Fogarty EE. Hip dysplasia in Hurler's syndrome: orthopaedic management after bone marrow transplantation. J Pediatr Orthop 1996;16: 731-3.
29. Odunusi E, Peters C, Krivit W, Ogilvie J. Genu valgum deformity in Hurler syndrome after hematopoietic stem cell transplantation: correction by surgical intervention. J Pediatr Orthop 1999;19:270-4.
30. Hite SH, Peters C, Krivit W. Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPSH 1). Pediatr Radiol 2000;30:464-70.
31. Wraith JE. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis 2001;24:245-50.
32. Kakkis ED, Muenzer J, Tiller GE, et al. Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 2001;344:182-8.
33. Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brook DA. Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet 2003;361:1608-13.